Journal of Natural Products
Note
nulohypoxylomanol B) via comparison of its HRESIMS and 1H
and 13C NMR data with those of compound 6.
(TLC) was performed using precoated silica gel 60 F254 and RP-18
F254S plates (both 0.25 mm, Merck, Darmstadt, Germany).
Fungal Material. JS540 was isolated from the leaves of
Z. caduciflora, collected from a swamp at Suncheon, South Korea.
The fungal strain (GenBank accession No. FJ478107.1) was identified
by one of the authors (S.K.). Parts of the material were deposited in
the Wildlife Genetic Resources Bank at NIBR. Leaf tissues were cut
into small pieces (0.5 × 0.5 cm), and surfaces were sterilized with 2%
sodium hypochlorite for 1 min and 70% ethanol for 1 min and then
washed with sterilized distilled water. Fungal strains were grown out
from plant tissues after about 7 days’ incubation on malt extract agar
(Difco) added to 50 ppm kanamycin, 50 ppm chloramphenicol, and
50 ppm Rose Bengal at 22 °C. Fungal strains were cultured by
transferring actively growing edges to a new potato dextrose agar
(Difco) and were stored as 20% glycerol stocks in a liquid nitrogen
tank.
Fermentation, Extraction, and Isolation. The fermentation was
performed in Erlenmeyer flasks (20 × 500 mL) on solid rice medium
containing 80 g of rice, 2.0 g of sea salt, and 80 mL of demineralized
water. After autoclaving at 121 °C for 20 min and then cooling to
room temperature, each flask was inoculated and then incubated at 28
°C under static conditions. After 30 days, the fermentation was
stopped by adding 500 mL of EtOAc to each flask. The extraction was
completed after the flasks had been shaken on a laboratory shaker at
150 rpm for 2 h.
Compound 8 was obtained as a yellow, amorphous solid. Its
molecular formula, C16H22O8, was determined based on
1
positive HRESIMS. Comparison of the H and 13C NMR
data (Tables 1 and 2) with those of compounds 1−3 suggested
that they have the same isochroman skeleton. Further
comparison of their 1D NMR data with several ribofuranosides
indicated that 8 is a ribofuranoside.13,14 The connection
between the sugar moiety and the skeleton via the O bond
was established by the key HMBC correlation between H-1′
(δH 5.59) and C-7 (δC 128.6). D-Ribose was identified as the
sugar moiety by measurement of its optical rotation following
acid hydrolysis ([α]2D5 −21.2 (c 0.095, H2O)).15,16 The sugar
moiety was further determined as α-D-ribofuranose through
comparison of the J1′,2′ value (4.2 Hz) with those of methyl-α-
D-ribofuranoside (J1,2 = 4.3 Hz) and methyl-β-D-ribofuranoside
(J1,2 = 1.2 Hz).17 Thus, compound 8 was identified as (3R)-6-
hydroxy-8-methoxy-3-methylisochroman 7-O-α-D-ribofuranose
(annulohypoxyloside).
To investigate the active anti-inflammatory constituents in
the ethyl acetate extract from A. truncatum, the production of
IL-12 p40, IL-6, and TNF-α in LPS-stimulated BMDCs was
evaluated. The cytotoxicity of compounds 1−8 (at a
concentration of 50 μM) against BMDCs was evaluated using
the MTT assay (Sigma, St. Louis, MO, USA). The results
showed that these compounds were inactive at the concen-
trations evaluated. To examine the effects of compounds 1−8
on the secretion of cytokines, their ability to inhibit the
production of IL-6, IL-12 p40, and TNF-α at a concentration of
50 μM was assessed. Xylariphilone (5) significantly decreased
the production of IL-6, IL-12 p40, and TNF-α; several of the
isolated compounds (1−4 and 6−8) had no effect at the
concentrations evaluated (IC50 > 100 μM). The effect of
compound 5 on the production of IL-6, IL-12 p40, and TNF-α
at various concentrations (2, 5, 10, 25, and 50 μM) was then
determined. SB203580, 4-[4-(4-fluorophenyl)-2-(4-methylsulfi-
nylphenyl)-1H-imidazol-5-yl]pyridine, an inhibitor of p38
kinase, which inhibits IL-6, IL-12 p40, and TNF-α production
with IC50 values of 3.5, 5.0, and 7.2 μM, respectively, was used
as a positive control.18 The results showed that compound 5
significantly inhibited the production of IL-6, IL-12 p40, and
TNF-α, with IC50 values of 5.3 0.8, 19.4 0.5, and 37.6
0.9 μM, respectively. Moreover, the observed anti-inflammatory
activities and structural features of compounds 1−8 provide
information regarding structure−activity relationships. Xylar-
iphilone (5) contains a ketone group (C-8), showed strong
activity. This suggests that the ketone group (C-8) of
isochroman derivatives plays an important role in the anti-
inflammatory activity.
The EtOAc solution was then evaporated under reduced pressure at
45 °C to give an EtOAc extract (28.5 g). The EtOAc extract (26.0 g)
was subjected to silica gel (5 × 30 cm) column chromatography with a
gradient of hexane−EtOAc−MeOH (30:1:0, 10:1:0, 4:1:0, 2:1:0;
1.5:1:0.12, 1:1:0.2, 0:5:1, 0:0:1; 1.5 L for each step) to give eight
fractions (Fr. 1A−1H). Fraction 1B (3.3 g) was separated using YMC
(2.0 × 80 cm) column chromatography with a MeOH−acetone−H2O
(0.2:0.2:1, 0.5:0.5:1, 1:1:1, 2:2:1, 4:4:1, 8:8:1; 1.0 L for each step)
elution solvent to give 16 fractions (Fr. 1B1−1B16). Fraction 1B2
(50.0 mg) was separated using silica gel (1 × 80 cm) column
chromatography with a hexane−EtOAc (2.5:1; 650 mL) elution
solvent to give compound 4 (39.0 mg). Fraction 1B4 (103.0 mg) was
separated using silica gel (1 × 80 cm) column chromatography with a
hexane−acetone−MeOH (6:1:0.1; 1.0 L) elution solvent to give
compound 5 (12.0 mg). Fraction 1B5 (110.0 mg) was separated using
silica gel (1 × 80 cm) column chromatography with a hexane−
acetone−MeOH (6:1:0.1; 1.0 L) elution solvent to give compound 7
(21.0 mg). Fraction 1B7 (22.0 mg) was separated using silica gel (1 ×
80 cm) column chromatography with a hexane−acetone (2:1; 800
mL) elution solvent to give compound 3 (16.0 mg). Fraction 1D (0.6
g) was separated using silica gel (1 × 80 cm) column chromatography
with a gradient of hexane−EtOAc−MeOH (6:1:0, 5:1:0, 3.5:1:0,
2:1:0.1; 550 mL for each step) elution solvent to give compounds 2
(71.0 mg) and 6 (14.0 mg) and three fractions (Fr. 1D1−1D3).
Fraction 1D1 (18.0 mg) was separated using silica gel (1 × 80 cm)
column chromatography with a hexane−acetone (5:1; 800 mL)
elution solvent to give compound 1 (2.5 mg). Fraction 1D3 (70.0 mg)
was separated using silica gel (1 × 80 cm) column chromatography
with a hexane−acetone−MeOH (6:1:0.1; 1.0 L) elution solvent to
give compound 8 (3.6 mg).
Annulohypoxyloman A (1): yellow, amorphous powder; [α]D25
−72.6 (c 0.1, MeOH); UV (MeOH) 204, 280 nm; 1H NMR
(pyridine-d5, 600 MHz) and 13C NMR data (pyridine-d5, 150 MHz),
see Tables 1 and 2; HRESIMS m/z 203.0678 [M + Na]+ (calcd for
203.0679, C10H12NaO3).
EXPERIMENTAL SECTION
■
General Experimental Procedures. Optical rotations were
determined using a Jasco DIP-370 automatic polarimeter. UV spectra
were recorded using a Beckman Du-650 UV−vis recording
spectrometer. The NMR spectra were recorded using a JEOL ECA
600 spectrometer (1H, 600 MHz; 13C, 150 MHz). The LCQ
Advantage trap mass spectrometer (Thermo Finnigan, San Jose, CA,
USA) was equipped with an electrospray ionization (ESI) source, and
high-resolution electrospray ionization mass spectra (HRESIMS) were
obtained using an Agilent 6530 Accurate-Mass Q-TOF LC/MS
system. Column chromatography was performed using silica gel
(Kieselgel 60, 70−230 and 230−400 mesh, Merck, Darmstadt,
Germany) and YMC RP-18 resins, and thin-layer chromatography
Annulohypoxyloman B (2): yellow, amorphous powder; [α]D25
−55.8 (c 0.1, MeOH); UV (MeOH): 205, 280 nm; 1H NMR
(methanol-d4, 600 MHz) and 13C NMR data (methanol-d4, 150
MHz), see Tables 1 and 2; HRESIMS m/z 233.0786 [M + Na]+ (calcd
for 233.0784, C11H14NaO4).
Annulohypoxyloman C (3): yellow, amorphous powder; [α]D25
−63.1 (c 0.1, MeOH); UV (MeOH) 204, 280 nm; 1H NMR
(methanol-d4, 600 MHz) and 13C NMR data (methanol-d4, 150
MHz), see Tables 1 and 2; HRESIMS m/z 247.0946 [M + Na]+ (calcd
for 247.0941, C12H16NaO4).
D
J. Nat. Prod. XXXX, XXX, XXX−XXX